Finding fusin/CXCR4, the first "2nd receptor" for HIV entry

被引：3
作者：
Berger, Edward A. [1 ]
机构：
[1] NIAID, Mol Struct Sect, Viral Dis Lab, NIH, Bethesda, MD 20892 USA
来源：
FRONTIERS IN IMMUNOLOGY | 2015年 / 6卷
关键词：
coreceptor; tropism; T cell line; macrophage; CCR5; CD4; Env glycoprotein; cell fusion; RECOMBINANT VACCINIA VIRUS; T-CELL LINES; ENVELOPE GLYCOPROTEIN; PRIMARY MACROPHAGES; TYPE-1; TROPISM; FUSION; INFECTION; SYSTEM;
D O I：
10.3389/fimmu.2015.00283
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Inhibition of CXCR4 expression by recombinant adenoviruses containing anti-sense RNA resists HIV-1 infection on MT4 cell lines
    Li, Wen-Gang
    Nie, Wei-Min
    Chen, Wei-Wei
    Jiang, Tian-Jun
    Xu, Xiao-Yuan
    Zhao, Min
    GENE, 2013, 526 (02) : 443 - 448
  • [42] Pairwise Comparison of Isogenic HIV-1 Viruses: R5 Phenotype Replicates More Efficiently Than X4 Phenotype in Primary CD4+ T Cells Expressing Physiological Levels of CXCR4
    Fiser, Anne-Laure
    Lin, Yea-Lih
    Portales, Pierre
    Mettling, Clement
    Clot, Jacques
    Corbeau, Pierre
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 53 (02) : 162 - 166
  • [43] A Conformationally Frozen Peptoid Boosts CXCR4 Affinity and Anti-HIV Activity
    Demmer, Oliver
    Frank, Andreas O.
    Hagn, Franz
    Schottelius, Margret
    Marinelli, Luciana
    Cosconati, Sandro
    Brack-Werner, Ruth
    Kremb, Stephan
    Wester, Hans-Juergen
    Kessler, Horst
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (32) : 8110 - 8113
  • [44] Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists
    Mishra, Rama K.
    Shum, Andrew K.
    Platanias, Leonidas C.
    Miller, Richard J.
    Schiltz, Gary E.
    SCIENTIFIC REPORTS, 2016, 6
  • [45] HIV-1 Co-Receptor Usage Based on V3 Loop Sequence Analysis: Preferential Suppression of CXCR4 Virus Post HAART?
    Jiao, Yanmei
    Wang, Pengfei
    Zhang, Hongwei
    Zhang, Tong
    Zhang, Yonghong
    Zhu, Huanzhang
    Wu, Hao
    IMMUNOLOGICAL INVESTIGATIONS, 2011, 40 (06) : 597 - 613
  • [46] Discoveries and developments of CXCR4-targeted HIV-1 entry inhibitors
    Zhang, Chaozai
    Zhu, Ruohan
    Cao, Qizhi
    Yang, Xiaohong
    Huang, Ziwei
    An, Jing
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2020, 245 (05) : 477 - 485
  • [47] Cell surface nucleolin interacts with CXCR4 receptor via the 212 terminal portion
    Niu, Hongxin
    Yang, Xiangshan
    Xu, Zhongfa
    Du, Tong
    Wang, Ruogu
    TUMOR BIOLOGY, 2015, 36 (02) : 1099 - 1104
  • [48] Detection of quasispecies variants predicted to use CXCR4 by ultra-deep pyrosequencing during early HIV infection
    Abbate, Isabella
    Vlassi, Chrysoula
    Rozera, Gabriella
    Bruselles, Alessandro
    Bartolini, Barbara
    Giombini, Emanuela
    Corpolongo, Angela
    D'Offizi, Gianpiero
    Narciso, Pasquale
    Desideri, Alessandro
    Ippolito, Giuseppe
    Capobianchi, Maria R.
    AIDS, 2011, 25 (05) : 611 - 617
  • [49] Synthesis and SAR of novel isoquinoline CXCR4 antagonists with potent anti-HIV activity
    Miller, John F.
    Gudmundsson, Kristjan S.
    Richardson, Leah D'Aurora
    Jenkinson, Stephen
    Spaltenstein, Andrew
    Thomson, Michael
    Wheelan, Pat
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (10) : 3026 - 3030
  • [50] Inhibition of HIV Fusion by Small Molecule Agonists through Efficacy-Engineering of CXCR4
    Berg, Christian
    Daugvilaite, Viktorija
    Steen, Anne
    Jorgensen, Astrid Sissel
    Vabeno, Jon
    Rosenkilde, Mette Marie
    ACS CHEMICAL BIOLOGY, 2018, 13 (04) : 881 - 886
12345